BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

740 related articles for article (PubMed ID: 11838730)

  • 1. Effect of different starting doses of levothyroxine on growth and intellectual outcome at four years of age in congenital hypothyroidism.
    Salerno M; Militerni R; Bravaccio C; Micillo M; Capalbo D; Di MS; Tenore A
    Thyroid; 2002 Jan; 12(1):45-52. PubMed ID: 11838730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mean High-Dose l-Thyroxine Treatment Is Efficient and Safe to Achieve a Normal IQ in Young Adult Patients With Congenital Hypothyroidism.
    Aleksander PE; Brückner-Spieler M; Stoehr AM; Lankes E; Kühnen P; Schnabel D; Ernert A; Stäblein W; Craig ME; Blankenstein O; Grüters A; Krude H
    J Clin Endocrinol Metab; 2018 Apr; 103(4):1459-1469. PubMed ID: 29325045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychological follow-up in early-treated congenital hypothyroidism: a problem-oriented approach.
    Bargagna S; Canepa G; Costagli C; Dinetti D; Marcheschi M; Millepiedi S; Montanelli L; Pinchera A; Chiovato L
    Thyroid; 2000 Mar; 10(3):243-9. PubMed ID: 10779139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Children with congenital hypothyroidism and their siblings: do they really differ?
    Rovet JF
    Pediatrics; 2005 Jan; 115(1):e52-7. PubMed ID: 15629966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Children with congenital hypothyroidism: long-term intellectual outcome after early high-dose treatment.
    Dimitropoulos A; Molinari L; Etter K; Torresani T; Lang-Muritano M; Jenni OG; Largo RH; Latal B
    Pediatr Res; 2009 Feb; 65(2):242-8. PubMed ID: 18787501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Earlier onset of treatment or increment in LT4 dose in screened congenital hypothyroidism: which as the more important factor for IQ at 7 years?
    Boileau P; Bain P; Rives S; Toublanc JE
    Horm Res; 2004; 61(5):228-33. PubMed ID: 15115051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial treatment dose of L-thyroxine in congenital hypothyroidism.
    Selva KA; Mandel SH; Rien L; Sesser D; Miyahira R; Skeels M; Nelson JC; Lafranchi SH
    J Pediatr; 2002 Dec; 141(6):786-92. PubMed ID: 12461494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of severe congenital hypothyroidism: closing the developmental gap with early high dose levothyroxine treatment.
    Dubuis JM; Glorieux J; Richer F; Deal CL; Dussault JH; Van Vliet G
    J Clin Endocrinol Metab; 1996 Jan; 81(1):222-7. PubMed ID: 8550756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of levothyroxine supplementation in extremely low birth weight infants who have transient hypothyroidism without thyroid-stimulating hormone elevation.
    Nomura S; Ikegami H; Wada H; Tamai H; Funato M; Shintaku H
    Osaka City Med J; 2014 Jun; 60(1):29-37. PubMed ID: 25272565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of high versus low initial doses of L-thyroxine for congenital hypothyroidism on thyroid function and somatic growth.
    Jones JH; Gellén B; Paterson WF; Beaton S; Donaldson MD
    Arch Dis Child; 2008 Nov; 93(11):940-4. PubMed ID: 18456702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Congenital Hypothyroidism: Impact of Secular Changes in Levothyroxine Initial Dose on Early Growth.
    Niuro L; Danner E; Viikari L; Kero J; Huopio H; Jääskeläinen J; Niinikoski H
    Horm Res Paediatr; 2023; 96(4):376-384. PubMed ID: 36476603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Head circumference and linear growth during the first 3 years in treated congenital hypothyroidism in relation to aetiology and initial biochemical severity.
    Ng SM; Wong SC; Didi M
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):155-9. PubMed ID: 15212659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurodevelopmental outcomes in congenital hypothyroidism: comparison of initial T4 dose and time to reach target T4 and TSH.
    Selva KA; Harper A; Downs A; Blasco PA; Lafranchi SH
    J Pediatr; 2005 Dec; 147(6):775-80. PubMed ID: 16356430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levothyroxine replacement in primary congenital hypothyroidism: the higher the initial dose the higher the rate of overtreatment.
    Tuhan H; Abaci A; Cicek G; Anik A; Catli G; Demir K; Bober E
    J Pediatr Endocrinol Metab; 2016 Feb; 29(2):133-8. PubMed ID: 26244672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of physical development of children with congenital hypothyroidism detected in the screening test--personal observations].
    Kik E; Noczyńska A
    Pediatr Endocrinol Diabetes Metab; 2011; 17(2):96-106. PubMed ID: 21722516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors in the intellectual development at 7 years of age in children with congenital hypothyroidism.
    Salerno M; Di Maio S; Militerni R; Argenziano A; Valerio G; Tenore A
    J Endocrinol Invest; 1995 Nov; 18(10):774-9. PubMed ID: 8787954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term Surveillance of Children with Congenital Hypothyroidism: Data from the German Registry for Congenital Hypothyroidism (AQUAPE "Hypo Dok").
    Ellerbroek VL; Bonfig W; Dörr HG; Bettendorf M; Hauffa B; Fricke-Otto S; Rohrer T; Reschke F; Schönau E; Schwab KO; Kapelari K; Röhl FW; Mohnike K; Holl RW
    Klin Padiatr; 2015 Jul; 227(4):199-205. PubMed ID: 26038964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of L-T4 as liquid solution improves the practicability and individualized dosage in newborns and infants with congenital hypothyroidism.
    von Heppe JH; Krude H; L'Allemand D; Schnabel D; Grüters A
    J Pediatr Endocrinol Metab; 2004 Jul; 17(7):967-74. PubMed ID: 15301044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of overt and subclinical hypothyroidism. Factors influencing L-thyroxine dosage.
    Rezzónico JN; Pusiol E; Saravi FD; Rezzónico M; Bossa N
    Medicina (B Aires); 1999; 59(6):698-704. PubMed ID: 10752211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IGF-1 and IGFBP in congenital and acquired hypothyroidism after long-term replacement treatment.
    Bona G; Rapa A; Boccardo G; Silvestro L; Chiorboli E
    Minerva Endocrinol; 1999 Jun; 24(2):51-5. PubMed ID: 10941423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.